Morten Seirup

Morten Seirup is a Senior Research Scientist 1 at Promega Corporation since September 2022, previously serving as an Assay Development PhD at Endsulin from November 2021 to July 2022 and as a Scientist at Dianomi Therapeutics from August 2020 to November 2021. Morten's academic background includes a PhD in Toxicology obtained from the University of Wisconsin-Madison, where participation spanned from January 2012 to December 2020, along with a Master of Science in Molecular Biology from Aarhus University, completed in December 2012. Prior education includes a Bachelor of Science in Molecular Biology from Aarhus University, which was attained in August 2009, and an exchange semester at the University of Wisconsin-Madison in 2010.